对ADHD的药理干预措施的有效性:更新系统审查和剂量反应网络元分析的协议
Mikail Nourredine1,2,3, Lucie Jurek4,5,6, Georgia Salanti7
1University of Southampton, Southampton, UK. mikail.nourredine@chu-lyon.fr.
Systematic reviews
|October 12, 2024
概括
这项研究分析了注意力缺陷/多动障碍 (ADHD) 的药物剂量,以找到最佳的治疗策略. 剂量反应网络的元分析将改善儿童和成人ADHD的管理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
背景情况:
- 注意缺陷/多动障碍 (ADHD) 影响全球5%的儿童,成人症状持续.
- 药物治疗是常见的,但最佳剂量对疗效和耐受性需要进一步研究.
研究的目的:
- 进行ADHD药理疗法的剂量反应网络元分析.
- 为了估计各种药物剂量的疗效.
- 为改善ADHD治疗结果的临床决策提供信息.
主要方法:
- 对ADHD药物随机对照试验 (RCT) 的最新系统审查.
- 没有语言限制的全面数据库搜索.
- 贝叶斯分层剂量反应建模,以确定最佳的剂量策略.
主要成果:
- 对于每种药物,剂量反应曲线将被估计.
- 根据疗效和耐受性数据,将确定最佳剂量策略.
- 分析将重点关注ADHD核心症状严重程度和治疗耐受性.
结论:
- 这种剂量反应网络的元分析将澄清药物剂量与ADHD治疗有效性之间的关系.
- 这些发现旨在帮助临床医生确定ADHD管理的最佳药物剂量.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.7K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.3K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
47
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
47
01:03Dose-Response Relationship: Overview
3.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.0K
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:23Antidepressant Drugs: MAOIs and Other Agents
197
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
01:21Drugs Affecting Neurotransmitter Release or Uptake
970
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
970
01:22Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K